PAVmed (PAVM) Accounts Payables (2015 - 2026)

PAVmed has reported Accounts Payables for 12 years, with the latest figure at $1.1 million in Q2 2026.

• On a quarterly basis, Accounts Payables rose 172.87% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a 172.87% increase from a year earlier, with the FY2025 full-year figure at $678000.0, up 3.2% from the prior year.
• Accounts Payables was $1.1 million for Q2 2026 at PAVmed, up from $678000.0 in the prior quarter.
• The five-year high for Accounts Payables was $8.2 million in Q1 2022, with the low at $342000.0 in Q3 2025.
• Average Accounts Payables over 5 years is $1.9 million, with a median of $1.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables jumped 334.34% in 2022, then sank 84.72% in 2023.
• Over 5 years, Accounts Payables stood at $2.7 million in 2022, then sank by 33.95% to $1.8 million in 2023, then slumped by 63.21% to $657000.0 in 2024, then grew by 3.2% to $678000.0 in 2025, then surged by 55.75% to $1.1 million in 2026.
• The last three Accounts Payables figures came in at $1.1 million (Q2 2026), $678000.0 (Q4 2025), and $342000.0 (Q3 2025), per Business Quant data.